SRA
Summit Rock Advisors Portfolio holdings
AUM
$355K
This Quarter Return
+6.21%
1 Year Return
+15.32%
3 Year Return
+85.97%
5 Year Return
+180.9%
10 Year Return
+226.74%
AUM
$167M
AUM Growth
+$167M
(-0.69%)
Cap. Flow
-$10.5M
Cap. Flow
% of AUM
-6.27%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Vanguard Value ETF
VTV
|
$9.69M |
| 2 |
Day One Biopharmaceuticals
DAWN
|
$558K |
| 3 |
monday.com
MNDY
|
$517K |
| 4 |
Dyne Therapeutics
DYN
|
$415K |
Top Sells
| 1 |
iShares Russell 2000 Value ETF
IWN
|
$21.7M |
Sector Composition
| 1 | Healthcare | 1.45% |
| 2 | Technology | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Value ETF
VTV
$144B
| $60.9M | 36.37% | 413,962 +65,885 | +19% | +$9.69M |
|
2
iShares Core S&P US Value ETF
IUSV
$22B
| $56.5M | 33.75% | 740,195 | – | – |
|
|
3
iShares Russell 2000 Value ETF
IWN
$11.8B
| $47.1M | 28.12% | 283,472 -130,580 | -32% | -$21.7M |
|
4
Clover Health Investments
CLOV
$1.34B
| $784K | 0.47% | 210,639 | – | – |
|
5
Phathom Pharmaceuticals
PHAT
$864M
| $671K | 0.4% | 34,100 | – | – |
|
|
6
Day One Biopharmaceuticals
DAWN
$769M
| $558K | 0.33% | +33,125 | New | +$558K |
|
|
7
monday.com
MNDY
$9.95B
| $517K | 0.31% | +1,676 | New | +$517K |
|
|
8
Dyne Therapeutics
DYN
$1.92B
| $415K | 0.25% | +34,887 | New | +$415K |
|